Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Recent Advnaces in the Treatment of Epilepsy
Arch Neurol 60:929-935, Nguyen,D.K. &Spencer,S.S., 2003
Vagus Nerve Stimulation and Drug Reduction
Neurol 56:561-563, Tatum,W.O.,et al, 2001
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
A 54-Year-Old Woman with Progressive Headache and Neurologic Decline
Neurol 102:e209190, Cheng,Y. & Zachariah,J., 2024
Treatment of Brain Metastases
J Clin Oncol 33:3475-3484, Lin, X. & DeAngelis, L.M., 2015
Acute Myopia and Angle Closure Glaucoma from Topiramate in a Seven-Year-Old: A Case Report and Review of the Literature
BMC Pediatrics 14:96, Rapoport, Y.,et al, 2014
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
NEJM 362:790-799, Glauser,T.A.,et al, 2010
Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009
Progressive Bone Deficit in Epilepsy
Neurol 70:170-176,166, Sheth,R.D.,et al, 2008
Bone Health in Young Women With Epilepsy After One Year of Antiepileptic Drug Monotherapy
Neurol 70:1586-1593, Pack,A.M.,et al, 2008
Cross-Sensitivity of Skin Rashes with Antiepileptic Drug Use
Neurol 71:1527-1534, Hirsch,L.J.,et al, 2008
Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007
Clinical Update:Diagnosis and Treatment of Essential Tremor
Lancet 369:1152-1154, Benito-Leon,J&Louis,E.D., 2007
Comparison and Predictors of Rash Associated with 15 Antiepileptic Drugs
Neurol 68:1701-1709, Arif,H.,et al, 2007
Epilepsy in Children
Lancet 367:499-524, Guerrini,R., 2006
The First Seizure and Its Management in Adults and Children
BMJ 332:339-342, Pohlmann-Eden,B.,et al, 2006
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Transient Lesion in the Splenium of the Corpus Callosum and Antiepileptic Drug Withdrawal
Neurol 65:1032-1036, Gurtler,S.,et al, 2005
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Trigeminal Neuralgia and Glossopharyngeal Neuralgia
Neurol Clin N Am 22:185-206, Rozen,T.D., 2004
Transient Lesion in the Splenium of the Corpus Callosum in an Epileptic Patient
Neurol 60:1838-1841, Mirsattari,S.M.,et al, 2003
Symptomatic SUNCT in an Eleven-Year-Old Girl
Neurol 60:2012-2013, Blattler,T.,et al, 2003
Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003
Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003
Antiepileptic Drug-Induced Bone Loss in Young Male Patients Who Have Seizures
Arch Neurol 59:781-786, Andress,D.L.,et al, 2002
Effect of Antiepileptic Drugs on Bone Density in Ambulatory Patients
Neurol 58:1348-1353, Farhat,G.,et al, 2002
Prognosis for Seizure Recurrence in Patients with Newly Diagnosed Neurocysticercosis
Neurol 59:1730-1734,1669, Carpio,A. &Hauser,W.A., 2002
Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001
Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000
Practice Parameter: Anticonvulsant Prophylaxis in Patients With Newly Diagnosed Brain Tumors
Neurol 54:1886-1893, Glantz,M.J.,et al, 2000
Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999
Cardiac Asystole and Bradycardia as a Manifestation of Left Temporal Lobe Complex Partial Seizure
Ann Int Med 130:581-583, Locatelli,E.R.,et al, 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis During First Weeks of Antiepileptic Therapy:A Case-Control Study
Lancet 353:2190-2194, Rzany,B.,et al, 1999
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998
Drug-Induced Pseudolymphoma Secondary to Lamotrigine
Neurol 50:1509-1510, Pathak,P.&McLachlan,R.S., 1998
Carbamazepine and Fatal Eosinophilic Myocarditis
NEJM 336:878-879, Salzman,M.B.,et al, 1997
Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997
Treatment of Trigeminal Neuralgia (Editorial)
NEJM 334:1125-1126, Fields,H.L., 1996
Postherpetic Neuralgia-Pathogenesis, Treatment and Prevention
NEJM 335:32-42, Kost,R.G.&Straus,S.E., 1996
A Randomized, Blinded, Placebo-Controlled Trial of Divalproex Sodium Prophylaxis in Adults with Newly Diagnosed Brain Tumors
Neurol 46:985-991, Glantz,M.J.,et al, 1996
The Course of Seizure Disorders in Patients with Malignant Gliomas
Arch Neurol 52:717-724, Moots,P.L.,et al, 1995
Carbamazepine Hypersensitivity Syndrome:Report of 4 Cases & Review of Literature
Medicine 74:144-151, DeVriese,A.S.P.,et al, 1995